Medican Enterprises, Inc. (MDCN)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Medican Enterprises, Inc. (MDCN) trades at $0.00 with AI Score 48/100 (Grade C). Medican Enterprises, Inc. is a bio-pharmaceutical company focused on the medical and recreational marijuana sector. Market cap: $2.88M, Sector: Real estate.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for MDCN: MDCN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MDCN against Real Estate peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MDCN: the 1 perspectives are evenly split.
How is this calculated? →Medican Enterprises, Inc. (MDCN) Real Estate Portfolio & Strategy
Medican Enterprises, Inc., founded in 1988, targets the burgeoning medical and recreational marijuana sector, planning investments in cultivation, distribution, and retail. Operating with a small team, the company seeks to establish a foothold in the evolving cannabis markets of the US and Canada.
What Is the Investment Thesis for MDCN?
Medican Enterprises, Inc. presents a speculative investment opportunity within the high-growth cannabis sector. The company's strategy to invest across the value chain, from cultivation to retail, could allow it to capture significant market share as the industry matures. However, the company's small size (3 employees) and negative profitability (Profit Margin: -16.9%) represent significant challenges. Key value drivers include successful execution of its investment strategy and favorable regulatory changes in the US and Canada. Upcoming catalysts include potential partnerships and expansion into new markets. Potential risks include intense competition, regulatory hurdles, and limited financial resources.
Based on FMP financials and quantitative analysis
MDCN Key Highlights
- Market Cap of $2.88M reflects the company's micro-cap status and limited market presence.
- P/E ratio of -28.15 indicates the company is currently unprofitable.
- Profit Margin of -16.9% highlights the company's challenges in achieving profitability.
- Beta of -13.37 suggests a high degree of volatility and potential sensitivity to market movements.
- No dividend is paid, reflecting the company's focus on reinvesting earnings for growth.
Who Are MDCN's Competitors?
MDCN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| OMH Ohmyhome Limited operates an online property platform in Singapore, Malaysia, and the Philippines, offering real estate brokerage services. The company | $0.50 | -0.82% | $11.48M | 68 |
| CRSS Crossroads Impact Corp. | $7.00 | +0.00% | $74.33M | 66 |
| SDWHF Soundwill Holdings Limited | $0.87 | -0.01% | $246.92M | 64 |
| NTPIF Nam Tai Property Inc. | $4.75 | +0.00% | $289.75M | 64 |
| WRFRF Wharf Real Estate Investment Company Limited | $2.70 | +0.00% | $8.20B | 51 |
| WE WeWork Inc. | $0.84 | -24.73% | $44.08M | 51 |
| AZLCZ Aztec Land and Cattle Company, Limited | $2442.00 | +0.00% | $222.22M | 51 |
| ASPZ Asia Properties, Inc. | $0.04 | +0.00% | $25.85M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MDCN's Key Strengths?
- Focus on a high-growth industry.
- Potential for early mover advantage.
- Investment across the cannabis value chain.
- Strategic location in Las Vegas, Nevada.
What Are MDCN's Weaknesses?
- Small size and limited resources.
- Negative profitability.
- Limited operating history.
- Dependence on regulatory changes.
What Could Drive MDCN Stock Higher?
- Potential partnerships with established cannabis companies to expand operations.
- Favorable regulatory changes in the United States and Canada regarding marijuana legalization.
- Successful development and launch of innovative cannabis products.
- Increasing consumer demand for medical and recreational marijuana.
- Expansion into new geographic markets as legalization progresses.
What Are the Key Risks for MDCN?
- Financial-distress signal — its Altman Z-Score of 0.50 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from established players in the cannabis industry.
- Regulatory hurdles and uncertainties surrounding marijuana legalization.
- Fluctuations in commodity prices for cannabis.
- Limited financial resources and negative profitability.
- Dependence on a small team of employees.
What Are the Growth Opportunities for MDCN?
- Growth opportunity 1: Expansion into new markets within the United States and Canada represents a significant growth opportunity for Medican Enterprises. As more states and provinces legalize marijuana, the company can capitalize on new market entrants. The North American cannabis market is projected to reach billions of dollars in the coming years, offering substantial growth potential for companies like Medican Enterprises that can successfully navigate the regulatory landscape and establish a strong market presence.
- Growth opportunity 2: Investment in research and development to create innovative cannabis products and services can drive growth for Medican Enterprises. By developing unique formulations, delivery methods, or applications of cannabis, the company can differentiate itself from competitors and capture a larger share of the market. The market for cannabis-infused products, such as edibles and beverages, is growing rapidly, presenting opportunities for companies that can develop innovative and appealing products.
- Growth opportunity 3: Strategic partnerships with established players in the cannabis industry can accelerate Medican Enterprises' growth. By collaborating with companies that have expertise in cultivation, processing, distribution, or retail, Medican Enterprises can leverage their resources and infrastructure to expand its operations and reach new customers. Partnerships can also provide access to valuable intellectual property and regulatory expertise.
- Growth opportunity 4: Development of a strong brand identity and marketing strategy can help Medican Enterprises stand out in the crowded cannabis market. By creating a recognizable and trusted brand, the company can build customer loyalty and attract new customers. Effective marketing strategies can also help to educate consumers about the benefits of cannabis and promote responsible use.
- Growth opportunity 5: Vertical integration across the cannabis value chain, from cultivation to retail, can improve Medican Enterprises' profitability and control over its supply chain. By owning and operating its own cultivation facilities, processing plants, and retail stores, the company can reduce costs, improve quality control, and capture a larger share of the profits generated by the cannabis industry. However, vertical integration requires significant capital investment and operational expertise.
What Opportunities Does MDCN Have?
- Expansion into new markets.
- Development of innovative products.
- Strategic partnerships.
- Increasing legalization of marijuana.
What Threats Does MDCN Face?
- Intense competition.
- Regulatory hurdles.
- Fluctuations in commodity prices.
- Changing consumer preferences.
What Are MDCN's Competitive Advantages?
- Early mover advantage in emerging markets.
- Potential for intellectual property development.
- Strategic partnerships within the industry.
- Focus on innovation and product differentiation.
What Does MDCN Do?
Medican Enterprises, Inc., established in 1988, is a bio-pharmaceutical company headquartered in Las Vegas, Nevada. The company's primary focus is on identifying and pursuing business opportunities within the medical and recreational marijuana sector. Medican Enterprises intends to invest across various segments of the cannabis industry, including cultivation, marketing, research and development, training, distribution, and retail sales. The company aims to capitalize on the growing legalization and acceptance of marijuana in the United States and Canada. With a small team of three employees, Medican Enterprises is currently in the early stages of its development. The company's strategy involves establishing a presence throughout the marijuana supply chain, from cultivation to retail distribution. By investing in research and development, Medican Enterprises seeks to develop innovative products and services that cater to the evolving needs of consumers in the medical and recreational marijuana markets. The company's business model focuses on strategic investments and partnerships to establish a strong foothold in this rapidly expanding industry.
What Products and Services Does MDCN Offer?
- Pursue business opportunities in the medical and recreational marijuana sector.
- Invest in the cultivation of marijuana.
- Invest in the marketing of marijuana products.
- Invest in research and development related to marijuana.
- Invest in training programs for the cannabis industry.
- Invest in the distribution of marijuana products.
- Invest in the retail sale of marijuana.
How Does MDCN Make Money?
- Invest in various segments of the cannabis industry.
- Generate revenue through the sale of marijuana products.
- Form strategic partnerships to expand operations.
- Focus on innovation and product development.
What Industry Does MDCN Operate In?
Medican Enterprises operates within the rapidly expanding medical and recreational marijuana industry. The market is characterized by increasing legalization, evolving regulations, and growing consumer demand. Competition is intense, with numerous companies vying for market share. Medican Enterprises aims to differentiate itself by investing across the value chain and focusing on innovation. The industry is projected to experience significant growth in the coming years, driven by increasing acceptance and wider availability of cannabis products.
Who Are MDCN's Key Customers?
- Medical marijuana patients.
- Recreational marijuana consumers.
- Businesses in the cannabis industry.
- Potential partners and investors.
Company Profile
Medican Enterprises, Inc. operates in the Real Estate - Services industry within the Real Estate sector. It is headquartered in Las Vegas, US. The company is led by CEO Kelvin Lindsey. MDCN has traded publicly since 1995.
F-Score 3/9Financial Health
Medican Enterprises, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.50 places it in the distress zone, a signal of elevated financial risk.
ROE 0%Key Financial Metrics
Return on equity for Medican Enterprises, Inc. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -3.6%, the inverse of the P/E and a quick read on earnings relative to price.
MDCN Valuation & Market Position
With a $2.88M market cap, Medican Enterprises, Inc. sits in the micro-cap segment of the market. Relative to its peer group, MDCN's quantitative score of 48/100 is below the peer average of 63/100.
MDCN Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Medican's future, indicating that those closest to the company believe in its potential.
- Community sentiment has shifted positively, with discussions highlighting promising developments in their product offerings.
- The cannabis sector is gaining traction, and Medican's positioning could capitalize on this growing market.
- Recent partnerships and collaborations have generated buzz, suggesting that Medican is aligning itself strategically for future growth.
Bear Case
- Concerns over regulatory challenges in the cannabis industry persist, which could impact Medican's operational capabilities.
- Recent social sentiment reflects skepticism about the company's long-term viability, with some investors questioning its business model.
- Insider selling activity was noted, raising red flags about potential internal issues or lack of confidence in future performance.
- Market perception remains cautious, as broader economic uncertainties could affect investor appetite for cannabis stocks like Medican.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MDCN Latest News
No recent news available for MDCN.
MDCN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MDCN.
Price Targets
Wall Street price target analysis for MDCN.
MDCN MoonshotScore
What does this score mean?
The MoonshotScore rates MDCN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Kelvin Lindsey
CEO
Kelvin Lindsey is the CEO of Medican Enterprises, Inc. His background and experience prior to joining Medican Enterprises are not detailed in the provided information. As CEO, he is responsible for leading the company's strategic direction and overseeing its operations in the medical and recreational marijuana sector. He manages a small team of three employees.
Track Record: Due to limited information, Kelvin Lindsey's track record at Medican Enterprises is unknown. There is no provided data on key achievements, strategic decisions, or company milestones under his leadership.
MDCN OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Medican Enterprises, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or even Pink. Companies in this tier often have limited operating history, minimal assets, and may be subject to greater price volatility and trading risks compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires a higher degree of due diligence and risk tolerance.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: OTC Other companies may have minimal or no financial reporting requirements, making it difficult to assess their financial health and performance.
- Low Liquidity: Limited trading volume and wide bid-ask spreads can make it difficult to buy or sell shares without incurring significant costs or price impact.
- Price Volatility: OTC stocks are often subject to greater price volatility due to lower trading volume and less regulatory oversight.
- Potential for Fraud: The OTC market has a higher risk of fraud and manipulation compared to major exchanges.
- Going Concern Risk: Companies on the OTC Other tier may have a higher risk of financial distress or bankruptcy.
- Verify the company's legal registration and business licenses.
- Obtain and review the company's financial statements (if available).
- Assess the company's management team and their experience.
- Research the company's industry and competitive landscape.
- Understand the company's business model and revenue streams.
- Evaluate the company's risk factors and potential liabilities.
- Consult with a qualified financial advisor.
- Longevity: The company was founded in 1988, suggesting some level of operational history.
- Headquarters: The company is headquartered in Las Vegas, Nevada, a major business hub.
- Industry Focus: The company operates in the growing medical and recreational marijuana sector.
- Publicly Traded: The company is publicly traded, which requires some level of regulatory compliance (though minimal on OTC Other).
MDCN Real Estate Stock FAQ
What does Medican Enterprises, Inc. do?
Medican Enterprises, Inc. is a bio-pharmaceutical company focused on capitalizing on opportunities within the medical and recreational marijuana sector. The company aims to invest in various aspects of the cannabis industry, including cultivation, marketing, research and development, training, distribution, and retail sales. By strategically investing across the value chain, Medican Enterprises seeks to establish a presence in the evolving cannabis markets of the United States and Canada.
What do analysts say about MDCN stock?
There is currently no available analyst coverage for Medican Enterprises, Inc. (MDCN). The company's micro-cap status and OTC listing likely contribute to the lack of analyst attention. Investors should conduct their own thorough research and due diligence before investing in MDCN, considering the company's financial performance, growth prospects, and risk factors. Key valuation metrics, such as revenue growth and profitability, should be carefully analyzed in the context of the cannabis industry.
What are the main risks for MDCN?
Medican Enterprises, Inc. faces several significant risks. The company's small size and limited resources pose challenges to its ability to compete effectively in the rapidly evolving cannabis industry. Regulatory uncertainties and potential changes in marijuana laws could also negatively impact the company's business. Furthermore, the company's negative profitability and dependence on external funding sources create financial risks. Investors should carefully consider these risks before investing in MDCN.
How does Medican Enterprises, Inc. compare to competitors in its industry?
Medican Enterprises, Inc. operates in a highly competitive industry with numerous companies vying for market share. Competitors range from large, well-established cannabis companies to smaller, niche players. Compared to some of its larger competitors, Medican Enterprises has limited resources and a smaller operational footprint. However, the company's focus on innovation and strategic partnerships could provide a competitive advantage. It is important to note that the provided peer tickers are not direct competitors in the cannabis industry, but rather companies in other sectors.
What are the key financial metrics investors watch for MDCN?
Given Medican Enterprises' focus on real estate and the cannabis industry, key financial metrics include revenue growth, profitability (gross margin, operating margin, net margin), and cash flow. Investors should also monitor the company's capital expenditures, debt levels, and return on invested capital. In the real estate context, metrics such as occupancy rates and rental yields may also be relevant. Analyzing these metrics in comparison to industry averages and competitors can provide insights into the company's financial performance and growth potential.
What are the key factors to evaluate for MDCN?
Medican Enterprises, Inc. (MDCN) holds an AI score of 48/100 (low). Not financial advice.
How frequently does MDCN data refresh on this page?
MDCN prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MDCN's recent stock price performance?
Medican Enterprises, Inc. (MDCN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on a high-growth industry. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on Medican Enterprises, Inc.
- OTC Other stocks carry higher risk.
- AI analysis pending.